Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Alterola Biotech, Inc.    ABTI

ALTEROLA BIOTECH, INC.

(ABTI)
SummaryQuotesChartsNewsCompany 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

ALTEROLA BIOTECH INC. : Changes in Registrant's Certifying Accountant (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
06/25/2019 | 01:04pm EDT

Item 4.01 Changes in Registrant's Certifying Accountant.

On June 24, 2019, the Company engaged AJSH & Co LLP, Chartered Accountants (the "New Accountant") as the Company's independent registered public accounting firm. The engagement of the New Accountant was approved by the Company's Board of Directors.

Prior to retaining the New Accountant, the Company did not consult with the New Accountant regarding either: (i) the application of accounting principles to a specified transaction, either contemplated or proposed, or the type of audit opinion that might be rendered on the Company's financial statements; or (ii) any matter that was the subject of a "disagreement" or a "reportable event" (as those terms are defined in Item 304 of Regulation S-K).

2

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ALTEROLA BIOTECH, INC.
01/09ALTEROLA BIOTECH INC. : Changes in Registrant's Certifying Accountant (form 8-K)
AQ
01/08ALTEROLA BIOTECH INC. : Changes in Registrant's Certifying Accountant, Other Eve..
AQ
2019ALTEROLA BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Di..
AQ
2019ALTEROLA BIOTECH INC. : Changes in Registrant's Certifying Accountant (form 8-K)
AQ
2019ALTEROLA BIOTECH INC. : Changes in Registrant's Certifying Accountant, Financial..
AQ
More news
Chart ALTEROLA BIOTECH, INC.
Duration : Period :
Alterola Biotech, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Lalit Kumar Verma Chief Executive Officer & Director
Peter Edwin Maddocks President, CFO, Secretary & Director
Irving Aronson Chairman
Dheeraj Jain Chief Operating Officer & Director
Sector and Competitors
1st jan.Capitalization (M$)
ALTEROLA BIOTECH, INC.0.00%82
GILEAD SCIENCES15.30%93 953
VERTEX PHARMACEUTICALS27.20%72 211
REGENERON PHARMACEUTICALS44.88%60 581
WUXI APPTEC CO., LTD.11.46%32 727
GENMAB A/S33.92%19 063